Medicaments based on progestins for dermal use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/565 (2006.01) A61K 8/63 (2006.01) A61K 8/67 (2006.01) A61K 9/06 (2006.01) A61K 31/375 (2006.01) A61K 31/56 (2006.01) A61K 31/569 (2006.01) A61K 31/57 (2006.01) A61K 47/22 (2006.01) A61K 47/10 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2422974

The present invention relates to semisolid transcutaneous medicaments based on at least one oxidation-sensitive progestin or a pharmaceutically acceptable derivative thereof. The medicaments comprise ascorbic acid, an ascorbic acid derivative or a salt thereof and have excellent stability. Corresponding gets which comprise a combination of norethisterone acetate and estradiol are described in particular.

La présente invention concerne des médicaments transcutanés semi-solides à base d'au moins une progestine sensible à l'oxydation ou un dérivé pharmaceutiquement acceptable de ladite progestine. Lesdits médicaments comprennent de l'acide ascorbique, un dérivé de l'acide ascorbique ou un sel de ces substances et présentent une excellente stabilité. La présente invention concerne également et plus particulièrement des gels correspondants qui comprennent de l'acétate de noréthistérone en association avec de l'ostradiol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicaments based on progestins for dermal use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments based on progestins for dermal use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments based on progestins for dermal use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1482346

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.